Vaxcell-Bio Therapeutics
323990.KQ
6.65 USD
0.09
+1.37%
v
Overview
Last close
6.65 usd
Market cap
152.70M usd
52 week high
18.71 usd
52 week low
6.48 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
5502.0967
Price/Book Value
2.8731
Enterprise Value
123.01M usd
EV/Revenue
27074.3827
EV/EBITDA
-86.7062
Key financials
Revenue TTM
27955.05 usd
Gross Profit TTM
11951.83 usd
EBITDA TTM
-8.16M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
61.08M usd
Net debt
N/A usd
About
Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea.
- Symbol323990.KQ
- ExchangeKQ
- IsinN/A
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CEO
- HeadquarterHwasun
- Web sitehttps://www.vaxcell-bio.com
